In order to determine and compare the potential inflammatory systemic effects of IA and IV IL-1α delivery, we evaluated levels of known pro-inflammatory cytokines in the serum of mice recovering from stroke with or without IL-1α treatment. The gene discussed is IL1A; the disease is Stroke.